Dr. Adam Slivka discusses the results of the study.
Mauna Kea Technologies announced positive results from FOCUS, a pivotal clinical trial on the use of probe-based Confocal Laser Endomicroscopy (pCLE) in biliary cancer detection. This trial enrolled 112 patients in 6 centers, 4 in the U.S., one in France, and one in Italy.
The publication appears in this month's issue of GIE as the highlighted paper with an accompanying editorial "Distinguishing malignant from benign biliary strictures: can confocal laser endomicroscopy close the gap?"
Thanks to the addition of pCLE during standard interventional procedures, the sensitivity of cancer detection jumps from 56% for ERCP + biopsies to 89% for ERCP + pCLE.